wellrank.ai
Epiq Scripts logo

Epiq Scripts

First cited by AI Jun 12, 2026

Surfaced organically in AI answers about compounded glp-1s. Not yet profiled.

AI Visibility

Visibility trend

Compounded GLP-1s, daily share of AI answers mentioning Epiq Scripts, through Jun 13, 2026.

8.3%

Avg position when mentioned: 7.0

By engine

Where Epiq Scripts is strong, and where it is invisible.

  • Perplexity
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 0 positive mentions
  • 2 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Epiq Scripts

PerplexityJun 13, 2026, 11:14 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

The providers in your results that explicitly say they use licensed U.S. pharmacies are OrderlyMeds and Empower Pharmacy.[1][2] OrderlyMeds says it “exclusively works with pharmacies based in the United States,” and that medication is compounded at “U.S. based licensed pharmacies.”[1] Empower Pharmacy says it offers compounded GLP-1 injections from its 503A PCAB-accredited compounding pharmacy and that it is “licensed to ship nationwide.”[2] A few other providers in your results say they use regulated or licensed compounding pharmacies, but the wording is less specific about U.S. licensing: Fridays says its compounded GLP-1 medications are sourced from “rigorously regulated pharmacies,” but the result does not name the pharmacies or explicitly say “licensed U.S. pharmacies” on that page.[8] Henry Meds is described in the search results as using 503A or 503B compounding pharmacies, including named partners such as Belmar, Strive, Epiq Scripts, and Casa Pharma Rx, but the result does not clearly state in the excerpt that all are licensed U.S. pharmacies.[6] If you want, I can turn this into a short buyer’s comparison of these providers based on pharmacy licensing, transparency, and GLP-1 availability.

Mentioned in position 7 of 8

Read full answer with sources →
PerplexityJun 12, 2026, 10:26 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

Based on the provided search results, the following compounded GLP-1 providers explicitly state that they use licensed US pharmacies (specifically citing 503A or 503B facilities based in the United States): OrderlyMeds Explicitly states they work "exclusively with pharmacies based in the United States." Lists specific US partners: SmartPharmaRx, Casa, and PerfectRx/PerfectionRx. Describes itself as a "100% online platform that connects patients to licensed healthcare professionals in all 50 states." Empower Pharmacy States their medications are made at a "503A PCAB-Accredited compounding pharmacy" (a US standard). Confirms they are licensed to "ship nationwide, including Puerto Rico," indicating a US-based operation. Henry Meds (and its partner Adonis Health Inc.) Described as "upfront" about using both 503A and 503B compounding pharmacies. Cites partner pharmacies: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx (all US-based entities). Fridays Weight Loss Program (joinfridays.com) States they "deliver from 503A and 503B certified compounding pharmacies." While they do not name all partners on marketing pages, they reference Beaker Pharmacy as a fulfillment partner. The FDA clarification mentioned in the text notes that compounded semaglutide must legally come from 503A pharmacies (US standard), which Fridays claims to use. Schaffner Pharmacy Explicitly states their products are made by "FDA certified 503B compounding pharmacies," which are US-regulated facilities. Important Regulatory Context (from results): FDA Shortage Status: As of May 2025, the FDA shortages for semaglutide and tirzepatide injections have been resolved. Consequently, pharmacies are generally no longer allowed to regularly compound "essentially copies" of commercially available GLP-1s. Current Availability: Compounded versions are now largely phased out and should only be used for specific medical needs that commercial products cannot meet (e.g., non-standard doses or removing allergens). 503A vs. 503B: 503A pharmacies are traditional compounding pharmacies licensed by state boards for individual patients, while 503B facilities are outsourcing facilities regulated by the FDA. Both are US-licensed entities. Summary: The providers most clearly identified as using licensed US pharmacies are OrderlyMeds, Empower Pharmacy, Henry Meds, Fridays, and Schaffner Pharmacy. OrderlyMeds is the most explicit about its exclusive use of US-based partners.

Mentioned in position 10 of 14

Read full answer with sources →

Public AI visibility history

Daily rank of Epiq Scripts on our buyer intent questions, per category. A dash means the engines did not cite Epiq Scripts at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
Compounded GLP-1s#77#34

TL;DR

Epiq Scripts is a compounding pharmacy operating in the telehealth and direct-to-consumer space, known primarily for compounded GLP-1 medications such as semaglutide. It has surfaced organically in AI-generated answers without yet having a formal public profile, currently ranking 14th in WellRank's Compounded GLP-1s category with 8% AI visibility and two neutral mentions in our corpus.

Company Overview

Epiq Scripts functions as a compounding pharmacy serving patients and prescribers seeking alternatives to brand-name GLP-1 receptor agonists. Its founding date and headquarters are not publicly disclosed in widely available sources. The business model centers on fulfilling prescriptions for compounded medications, often in coordination with telehealth providers or directly with patients.

Product Features

  • Compounded semaglutide preparations
  • Compounded tirzepatide preparations
  • GLP-1 injectable formulations for weight management
  • Prescription fulfillment for telehealth-referred patients
  • Custom dosing options associated with compounding pharmacy services

Target Market

Epiq Scripts primarily serves adult patients pursuing compounded GLP-1 therapies for weight loss or metabolic health, typically those seeking lower-cost alternatives to branded drugs like Ozempic or Wegovy. Its geographic reach is not publicly confirmed, though compounding pharmacies of this type commonly ship across much of the United States where regulations permit.

Buyer Personas

  • A cost-conscious adult managing obesity who has been prescribed semaglutide but cannot afford or access the brand-name version.
  • A telehealth patient referred by an online weight-loss platform looking for a fulfillment pharmacy.
  • A medically supervised weight-loss program participant whose provider works with independent compounding pharmacies.
  • A returning GLP-1 user who has previously used a competitor such as Empower Pharmacy or a platform like Fridays and is exploring alternatives.

Funding & Performance

Funding stage, investor backing, valuation, and revenue figures for Epiq Scripts are not publicly disclosed.

Recent Developments

Epiq Scripts has gained organic visibility in AI answer engines amid broad industry discussion about the future of compounded GLP-1 drugs, a category under active FDA scrutiny. As Scientific American has reported, regulatory pressure on compounded semaglutide and tirzepatide is intensifying, which is shaping the operational environment for all compounding pharmacies in this space. No specific product launches or corporate milestones are publicly confirmed for Epiq Scripts at this time.

Competitive Landscape

According to WellRank co-mention data, AI engines most frequently surface Epiq Scripts alongside OrderlyMeds, Henry Meds, Fridays, Empower Pharmacy, Casa Pharma Rx, Strive Pharmacy, and SmartPharmaRx. This peer set spans both direct compounding pharmacies and telehealth platforms that source from compounders, reflecting the blended competitive landscape for compounded GLP-1s. A broader overview of how these options compare is available in resources such as this compounding pharmacy roundup and the American Med Spa Association's compounded GLP-1 FAQ.

Epiq Scripts vs the brands AI recommends alongside it

The real competitive set in Compounded GLP-1s: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Epiq Scripts logo
Epiq ScriptsThis brand
#34
8.3%
Casa Pharma Rx logo
Casa Pharma Rx

2 shared answers

#35
8.3%
Empower Pharmacy logo
Empower Pharmacy

2 shared answers

#2
41.7%
Fridays logo
Fridays

2 shared answers

#36
8.3%
Henry Meds logo
Henry Meds

2 shared answers

#4
33.3%

Email me when overtakes Epiq Scripts

One email the day the ranks flip. Nothing else.

User Sentiment

Within WellRank's current AI corpus, both mentions of Epiq Scripts are neutral in tone, with no positive or cautious signals recorded. This pattern is consistent with a brand that AI engines cite as a factual option within a category rather than one they evaluate or endorse. Public consumer sentiment is not well established in widely indexed review sources at this time.

Pricing

Pricing for Epiq Scripts compounded medications is not published in any widely available public source and is therefore not disclosed here. Pricing in the compounded GLP-1 category broadly varies by formulation, dosage, and supply duration, as noted in resources like GoodRx's coverage of compounded GLP-1 costs.

Sources cited around Epiq Scripts

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Epiq Scripts weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Epiq Scripts? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.